IPS PharmaAbout Master Kush
MSKIndicaThis mostly Indica strain gained popularity in coffee shops there as a unique tetraploid strain. Most cannabis strains are diploid. They have two sets of chromosomes, one from each parent in each cell.
Bred by 
Dutch White Label Seed Company
Master Kush is a strain originally named High Rise, which comes from south Amsterdam. This mostly Indica strain gained popularity in coffee shops there as a unique tetraploid strain. Most cannabis strains are diploid. They have two sets of chromosomes, one from each parent in each cell. Tetraploid strains carry four times the number of haploid chromosomes, making eight sets.
The strain has won several awards over the years. It won The Cannabis Cup, known as the Superbowl of pot, twice - once in 1992 and again in 1993. It is also the strain of choice for none other than Snoop Lion (Snoop Dog).
Since the arrival of Master Kush, other strains have also taken up this name. Some are crosses of true Master Kush, but others are mere imitations.
Description provided by Wikileaf.
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About Somai Pharmaceuticals Inc.
Somaí, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specialising in cannabinoid-based medicines, is driving the global pharmaceutical cannabis market with a broad portfolio of EU-GMP-certified extracts.
Somaí is building a global brand focused on innovative cannabis-based therapeutics, with a vision of people living healthier lives supported by natural cannabis medicines.
The core strength of Somaí lies in its EU-GMP certification, which represents the gold standard for pharmaceutical manufacturing worldwide. This is particularly important in markets like the U.K., where there is a clear distinction between fully EU-GMP pharmaceutical products and less stringently regulated “Specials” or compounded extracts.
Somaí owns and operates its facilities under this highest standard:
- Somaí Pharmaceuticals – a state-of-the-art manufacturing facility in Lisbon, Portugal
- NovaSoma – an indoor cultivation facility, also in Lisbon, Portugal
Complete vertical integration—from indoor cultivation through to finished-dose manufacturing—under strict EU-GMP rules ensures batch-to-batch consistency, long-term stability data, and chemical reproducibility for patients. This level of quality and regulatory adherence allows Somaí's products to be supplied globally as true finished-dosage pharmaceutical extracts.
This commitment to the EU-GMP pharmaceutical standard enables Somaí to compete directly with established pharmaceutical manufacturers and to build one of the most advanced certified cannabinoid-containing extract portfolios worldwide.
somaipharma.eu
Further National Health-Service Information on